These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14519422)

  • 1. Rosiglitazone-induced protection against myelotoxicity produced by 5-fluorouracil.
    Benko I; Djazayeri K; Abrahám C; Zsuga J; Szilvássy Z
    Eur J Pharmacol; 2003 Sep; 477(2):179-82. PubMed ID: 14519422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment.
    Djazayeri K; Szilvássy Z; Peitl B; Németh J; Nagy L; Kiss A; Szabó B; Benko I
    Eur J Pharmacol; 2005 Oct; 522(1-3):122-9. PubMed ID: 16213483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rosiglitazone, an insulin sensitizer, on myelotoxicity caused by repeated doses of 5-fluorouracil.
    Djazayeri K; Szilvássy Z; Benko K; Rózsa B; Szabó B; Szentmiklósi AJ; Benko I
    Pharmacol Res; 2006 Feb; 53(2):156-61. PubMed ID: 16338143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium oxonate modulation of 5-fluorouracil-induced myelotoxicity in murine and human colony forming assays of hematopoietic precursor cells.
    Kouchi Y; Maeda Y; Ohuchida A; Nomura N
    Toxicol Lett; 2002 Sep; 135(1-2):11-8. PubMed ID: 12243859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
    Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
    Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil.
    Neta R; Keller JR; Ali N; Blanchette F; Dubois CM
    Radiat Res; 1996 May; 145(5):624-31. PubMed ID: 8619029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Chemoprotective Activity of Bovine Dialyzable Leukocyte Extract in Mouse Bone Marrow Cells against Damage Induced by 5-Fluorouracil.
    Coronado-Cerda EE; Franco-Molina MA; Mendoza-Gamboa E; Prado-García H; Rivera-Morales LG; Zapata-Benavides P; Rodríguez-Salazar Mdel C; Caballero-Hernandez D; Tamez-Guerra RS; Rodríguez-Padilla C
    J Immunol Res; 2016; 2016():6942321. PubMed ID: 27191003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone Promotes Bone Marrow Adipogenesis to Impair Myelopoiesis under Stress.
    Lu W; Wang W; Wang S; Feng Y; Liu K
    PLoS One; 2016; 11(2):e0149543. PubMed ID: 26895498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
    Varas F; Bernard A; Bueren JA
    Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
    Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
    Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of cytotoxic agents to granulocyte-macrophage progenitors is increased in obese Zucker and non-obese but insulin resistant Goto-Kakizaki rats.
    Géresi K; Benkő K; Szabó B; Megyeri A; Peitl B; Szilvássy Z; Benkő I
    Eur J Pharmacol; 2012 Dec; 696(1-3):172-8. PubMed ID: 23022328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
    Moore MA; Warren DJ
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7134-8. PubMed ID: 3499607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of 5-fluorouracil on the clonogenic hematopoietic cells (CFU-S) of embryonic and sexually mature mice].
    Domaratskaia EI; Starostin VI; Prianishnikova OD
    Izv Akad Nauk Ser Biol; 1995; (4):398-402. PubMed ID: 7496312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelotoxicity induced in female B6C3F1 mice by inhalation of methyl isocyanate.
    Hong HL; Bucher JR; Canipe J; Boorman GA
    Environ Health Perspect; 1987 Jun; 72():143-8. PubMed ID: 3622428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice.
    Abe F; Matsuda A; Schneider M; Talmadge JE
    Cancer Immunol Immunother; 1990; 32(2):75-80. PubMed ID: 2289207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant human granulocyte colony-stimulating factor on variations of morphologically identifiable bone marrow cells in myelosuppressed mice.
    Kabaya K; Kusaka M; Seki M
    In Vivo; 1994; 8(6):1033-9. PubMed ID: 7539636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of leukotactin-1 on the protection in vivo of myeloid progenitor cells against cytotoxic chemotherapeutics.
    Kim WY; Broxmeyer HE; Han IS; Park DH; Lee KM; Vinay DS; Kwon BS
    J Hematother Stem Cell Res; 2003 Feb; 12(1):107-13. PubMed ID: 12662441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.